Follow on Google News News By Tag News By Place Country(s) Industry News
Follow on Google News | Perceptronix Announces Publication of Important Clinical Study Evaluating its Oral Cancer TestPerceptronix Medical Inc. (PMI) today announced that the results from the study of its OralAdvance™ test for detection of Oral Cancer are published in the September 2012 issue of Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.
By: Perceptronix Medical Inc OralAdvance™ “We are very pleased with the results of this study, which establishes OralAdvance™ The paper appears in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, Volume 114, Issue 3 (September 2012 issue).which is the official publication for the American College of Oral and Maxillofacial Surgery, American Academy of Oral and Maxillofacial Radiology, American Academy of Oral Medicine, and the American Academy of Oral and Maxillofacial Pathology About Perceptronix Medical Inc. Perceptronix Medical Inc. ("PMI") provides anatomic pathology and cancer diagnostics services to medical and dental practices and facilities in support of earlier diagnoses for better patient outcomes. The company uniquely specializes in early cancer detection using quantitative cytology, computer-aided measurement of large-scale DNA abnormality that can indicate precancerous or cancerous changes. PMI has developed two proprietary tests using its ClearCyte™ technology. For further information contact: Alexei Doudkine Director, Business Development & Clinical Affairs PMI Labs Suite 400 - 555 West 8th Avenue Vancouver, BC, V5Z 1C6 Phone: 604-629- Email: alexei.doudkine@ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|